Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06427824
What this trial is testing

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

Who this might be right for
Bladder Cancer
University of Chicago 85
Not applicableLooking for participantsNCT06988696
What this trial is testing

The Effect of Perioperative Heated Sock Application on Hypothermia and Vital Signs in Bladder Tumor Surgery

Who this might be right for
Bladder Tumor
Istanbul University - Cerrahpasa 90
Testing effectiveness (Phase 2)Study completedNCT00234494
What this trial is testing

Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer

Who this might be right for
Bladder Cancer
Christopher Sweeney, MBBS 45
Not applicableStudy completedNCT06768346
What this trial is testing

Hyperthermic Intra-Vesical Chemotherapy

Who this might be right for
Bladder Cancer
Queen Mary University of London 259
Early research (Phase 1)Study completedNCT03330561
What this trial is testing

PRS-343 in HER2-Positive Solid Tumors

Who this might be right for
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Bladder Cancer+1 more
Pieris Pharmaceuticals, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT04892342
What this trial is testing

Study of ESG401 in Adults With Solid Tumors

Who this might be right for
Neoplasms, BreastNeoplasms, LungNeoplasms,Colorectal+3 more
Shanghai Escugen Biotechnology Co., Ltd 156
Early research (Phase 1)Looking for participantsNCT07483970
What this trial is testing

A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.

Who this might be right for
High Risk Non-muscle Invasive Bladder Cancer
Jecho Biopharmaceuticals Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT00343356
What this trial is testing

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder

Who this might be right for
Bladder Neoplasms
LanZhou University 138
Not applicableUnknownNCT05207969
What this trial is testing

Efficacy of the Act of Urination to Relief the Pain During Flexible Cystoscopy Procedure.

Who this might be right for
HematuriaBladder CaBladder Stone+1 more
Universiti Sains Malaysia 58
Testing effectiveness (Phase 2)Study completedNCT02736266
What this trial is testing

Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma

Who this might be right for
Urothelial Bladder Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 174
Post-approval studies (Phase 4)UnknownNCT01876836
What this trial is testing

Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications

Who this might be right for
Bladder TumourProstate Hyperplasia
Diskapi Yildirim Beyazit Education and Research Hospital 120
Not applicableStudy completedNCT00913536
What this trial is testing

Cone Beam Computed Tomography (CT) Bladder

Who this might be right for
Bladder Cancer
University Health Network, Toronto 30
Post-approval studies (Phase 4)Looking for participantsNCT06764095
What this trial is testing

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial CarcinomaMetastatic Bladder Urothelial Carcinoma+4 more
Mayo Clinic 75
Early research (Phase 1)Study completedNCT03023319
What this trial is testing

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungMesotheliomaBladder Cancer+5 more
Nagla Abdel Karim 6
Large-scale testing (Phase 3)Study completedNCT02145871
What this trial is testing

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 282
Not applicableLooking for participantsNCT05969964
What this trial is testing

Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins

Who this might be right for
Bladder Cancer Stage I
Mansoura University 370
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Large-scale testing (Phase 3)Ended earlyNCT04688931
What this trial is testing

UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 282
Not applicableNot Yet RecruitingNCT07781956
What this trial is testing

Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Nanjing First Hospital, Nanjing Medical University 40
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Next Page